MBCP Gel™ is intended for use as a bone grafting material to fill, augment or reconstruct osseous bone defects in particular in periodontal or oral/maxillofacial applications. These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. MBCP Gel™ can generally be used for bone filling in closed cavities. MBCP Gel™ can be used with autogenous bone grafting materials. Typical uses include but are not limited to: - Periodontal/Infrabony defects - Ridge augmentation - Extraction sites (implant preparation/placement) - Sinus lifts - Cystic cavities
Device Story
MBCP Gel™ is a synthetic, resorbable bone graft substitute provided in a pre-filled syringe for single-patient use. It consists of biphasic calcium phosphate particles (60% hydroxyapatite, 40% beta-tricalcium phosphate) suspended in a pharmaceutical-grade hydroxypropylmethylcellulose aqueous gel carrier. The gel acts as a binder and spacer for the particles, facilitating handling and placement into osseous defects. The device is applied by a clinician during oral/maxillofacial surgical procedures. Once implanted, the gel provides an environment for bone ingrowth; the material is gradually resorbed and replaced by newly formed bone. It is intended for use in periodontal defects, ridge augmentation, extraction sites, sinus lifts, and cystic cavities, either alone or mixed with autogenous bone.
Clinical Evidence
No clinical data provided; substantial equivalence is supported by design, material, and performance information.
Technological Characteristics
Synthetic bone graft material composed of 60% hydroxyapatite and 40% beta-tricalcium phosphate particles in a hydroxypropylmethylcellulose aqueous gel carrier. Sterile, single-patient use, syringe-delivered. Resorbable, non-self-setting.
Indications for Use
Indicated for patients requiring bone grafting to fill, augment, or reconstruct osseous defects in periodontal or oral/maxillofacial applications, including surgically created defects or those resulting from traumatic injury. Suitable for use in closed cavities and in conjunction with autogenous bone grafting materials.
Regulatory Classification
Identification
Bone grafting material is a material such as hydroxyapatite, tricalcium phosphate, polylactic and polyglycolic acids, or collagen, that is intended to fill, augment, or reconstruct periodontal or bony defects of the oral and maxillofacial region.
Special Controls
*Classification.* (1) Class II (special controls) for bone grafting materials that do not contain a drug that is a therapeutic biologic. The special control is FDA's “Class II Special Controls Guidance Document: Dental Bone Grafting Material Devices.” (See § 872.1(e) for the availability of this guidance document.)(2) Class III (premarket approval) for bone grafting materials that contain a drug that is a therapeutic biologic. Bone grafting materials that contain a drug that is a therapeutic biologic, such as biological response modifiers, require premarket approval.
(c)
*Date premarket approval application (PMA) or notice of product development protocol (PDP) is required.* Devices described in paragraph (b)(2) of this section shall have an approved PMA or a declared completed PDP in effect before being placed in commercial distribution.
{0}------------------------------------------------
1 of 2
Image /page/0/Picture/1 description: The image shows the logo for "Biomatlante". The logo consists of a stylized hexagon shape in black, with a jagged, uneven edge at the top, resembling a natural or organic form. Below the shape, the word "Biomatlante" is written in a simple, sans-serif font, with thin lines giving it a clean and modern appearance.
Image /page/0/Picture/2 description: The image shows a handwritten string of characters, "K060732". The characters are written in a dark ink on a white background. The handwriting is somewhat stylized, with the numbers having a rounded appearance.
JUN - 2 2006
-Confidential-
MBCP Gel™
# 510(k) Summary of Safety and Effectiveness
This 510(k) Summary for MBCP™ is provided as required per Section 513(1)(3) of the Food, Drug
and Cosmetic Act and Cosmetic Act.
## 1. GENERAL INFORMATION
| Submitter's name and adress : | BIOMATLANTE |
|-------------------------------|-----------------------------------|
| | ZA DES IV NATIONS |
| | 5, rue Edouard Belin |
| | -F- 44360 VIGNEUX DE BRETAGNE |
| | France |
| Contact : | Myriam VINCENT, |
| | Regulatory Affairs Manager |
| | Tel : +33 228 02 00 09 |
| | myriamvincent@biomatlante.com |
| FDA Establishment Number : | 3002673655 |
| Trade Name: | MBCP Gel™ |
| Common Name: | Dental Bone Graft |
| Classification Name : | Bone Grafting Material, Synthetic |
| Product Code : | LYC |
| CFR Section : | 872.3930 |
| Device Panel : | Dental |
Summary preparation date:
March 6", 2006.
## 2. PREDICATE DEVICES
The subject device is substantially equivalent to similar previously cleared devices.
## 3. DEVICE DESCRIPTION
MBCP Gel™ is a Resorbable Bone Graft Substitute that is rapidly replaced by newly-formed bone. This material is a non self setting gel providing mechanical resistance after healing and osseous rehabilitation.
MBCP Gel™ is composed of biphasic Calcium Phosphate (60% Hydroxyapatite (HA) and 40% beta-Tricalcium Phosphate (β-ΤCP)) particles associated with an excipient with an excipient with an excipient with pharmaceutical grade (p TOP)) particles "associated" with "an" excipient" welicle of
pharmaceutical grade quality (hydroxypropylmethylcellulose in an aqueous solution). The s
Rev. 03/06/2006
Section 04 Page 1 of 2
{1}------------------------------------------------
Image /page/1/Picture/0 description: The image shows the logo for Biomatiante. The logo consists of a black hexagon shape in the upper left corner, with the word "Biomatiante" written in a thin, sans-serif font below it. The text is slightly faded, giving it a subtle, textured appearance.
K060732
2072
-Confidential-
MBCP Gel™
## 510(k) Summary of Safety and Effectiveness
carrier acts as a spacer and a binder of the particles. MBCP Gel™ provides an environment for bone ingrowth. On time MBCP Gel™ is fully resorbable.
MBCP Gel™ is provided sterile for single patient use in a syringe.
#### 4. INTENDED USE
MBCP Gel™ is intended for use as a bone grafting material to fill, augment or reconstruct osseous bone defects in particular in periodontal or oral/maxill/facial (d) 1).
The marticular in periodontal or oral/maxill/facial applications.
These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone.
MBCP Gel™ can generally be used for bone filling in closed cavities.
MBCP Gel™ can be used with autogenous bone grafting materials.
Typical uses include but are not limited to:
- Periodontal/Infrabony defects .
- ◆ Ridge augmentation
- Extraction sites (implant preparation/placement) .
- Sinus lifts .
- . Cystic cavities
#### SUBSTANTIAL EQUIVALENCE INFORMATION 5.
The principal component and intended use of MBCP Gel™ is the same as previously cleared MBCP™ (K051885). MBCP Gel™ and the predicate devices are substantially equivalent in design, materials of construction and function.
The safety and effectiveness of MBCP Gel™ as a modification to MBCP™ presented in this submission is adequately supported by the substantial equivalence information, safety and performance data provided within this Premarket Notification.
Rev. 03/06/2006
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image shows the seal of the Department of Health and Human Services (HHS) of the United States. The seal features a stylized caduceus, a symbol often associated with medicine and healthcare, with three lines forming the snake and staff. The text "DEPARTMENT OF HEALTH AND HUMAN SERVICES. USA" is arranged in a circular pattern around the caduceus.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUN - 2 2006
Ms. Myriam Vincent Regulatory Affairs Manager Biomatlantc ZA LES IV Nations 5. Rue Edouard Berlin F-44360 Vingneus de Bretagne FRANCE
Re: K060732
Trade/Device Name: MBCP GeI™ Regulation Number: 872.3930 Regulation Name: Bone Grafting Material Synthetic Regulatory Class: II Product Code: LYC Dated: March 6, 2006 Received: March 20, 2006
Dear Ms. Vincent:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{3}------------------------------------------------
Page 2 - Ms. Vincent
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820): and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act): 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801). please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Shin-Jye, Ph.D.
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
K060732
## Indications for Use
510(k) Number (if known):
Device Name: MBCP Gel™
## Indications For Use:
MBCP Gel™ is intended for use as a bone grafting material to fill, augment or reconstruct osseous bone defects in particular in periodontal or oral/maxillofacial applications.
These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone.
MBCP Gel™ can generally be used for bone filling in closed cavities.
MBCP Gel™ can be used with autogenous bone grafting materials.
Typical uses include but are not limited to:
- . Periodontal/Infrabony defects
- Ridge augmentation .
- Extraction sites (implant preparation/placement) .
- . Sinus lifts
- Cystic cavities .
Prescription Use " Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
| Concurrence of CDRH, Office of Device Evaluation (ODE) | |
|----------------------------------------------------------------------------------|-----------|
| Division Sign-Off) | |
| Division of Anesthesiology, General Hospital,<br>Section Control, Dental Devices | Page 1 of |
| 510(k) Number: | K060732 |
Two short videos show you everything — or skip straight to the written tutorial if you'd rather read. You can reopen this any time from the Tutorial button in the top bar.
Part 1 — Search, results, and everyday workflows 16 min
Part 2 — Embeddings: the galaxy map 3 min
1. Search: exact and fuzzy
Type a phrase like "coronary artery calcification" into the search box. You get two kinds of results. Exact results match the literal phrase — prefix searches work ("coronary artery calcificati") but suffix searches do not. Fuzzy results match on the meaning and intent of your phrase rather than the exact words, and are sorted by relevance score. Hover over the Exact or Fuzzy badge on any row to see exactly why it matched.
Use the checkboxes above the results to narrow: SaMD keeps only software-only devices, AI / ML keeps only devices with AI.
Exact vs. fuzzy search: what's the difference?
Exact matches on the literal phrase (prefix search works, suffix does not). Fuzzy matches on the meaning and intent of the phrase rather than the exact words. Hover over the badge on any row to see why it matched.
You search "coronary artery calcification" and want only software devices with AI. What two filters do you apply?
Narrow by SaMD (software-only devices), then narrow by AI/ML (devices with AI).
2. The results table
Scroll right in the results table. The intended use is extracted for you — no need to open the PDF. The device story gives a high-level snapshot of what the device does and how it's used. The AI Performance sub-table shows each output name, acceptance criteria, observed values, and development/test dataset descriptions — the same format Innolitics uses for regulatory strategy outputs, and the fastest high-level fingerprint of an AI device. It is AI-generated but has been very reliable in practice.
Where do you find a device's intended use without opening the PDF?
Scroll right in the search results table. The intended use column is extracted for you; no need to dig into the 510(k) summary PDF.
What does the AI Performance sub-table show, and why is it useful?
Output name, acceptance criteria, observed values, development dataset description, and test dataset description. It's the same format we use for regulatory strategy output and Fast 510(k) input, and the fastest high-level fingerprint of an AI device. AI-generated but reliable in practice.
3. Judging fuzzy relevance
Fuzzy results trail off in relevance as you scroll. Use three signals to decide how far down to go: the fuzzy badge explanations, the intended use column, and whether your target output (e.g., Cobb angle) still appears in the AI Performance sub-table. Once it stops appearing, you're past the relevant zone. A top hit with a low score (~0.4) and a stretched explanation is a hint the closest predicates are far away — the project may be headed for De Novo. Note the fuzzy search is a pattern match: it doesn't handle negation ("not") well, and hardware devices can appear — filter by SaMD/AI ML to cut them.
How do you judge how far down fuzzy search results to go?
Use the relevancy signals: the fuzzy badge explanations, the intended use column, and whether the target output (e.g., Cobb angle) still appears in the AI Performance sub-table. Once it stops appearing, results are trailing off in relevancy.
4. Device detail page: chat and citations
Click a device name to open its detail page: device facts on the left, a chat window on the right. Ask something like "Describe the training data". The answer carries little citation bubbles — click one to jump to the highlighted passage in the source PDF, so you can verify every AI answer against the document. There's also a Download PDF button for sharing.
How do you verify an AI chat answer on the device detail page?
Click the citation bubbles to jump to the relevant highlight in the source document.
Reading rule for every project: how many summaries do you read in full?
At least the three most relevant 510(k) or De Novo summaries, in full. After that, use targeted chat questions to confirm your memory quickly. The tool supports this professional habit — it doesn't replace it.
5. Side-by-side comparison
Select multiple rows in the results table (aim for under ~10), then open the PDF Viewer tab. Ask one question — it goes to all selected devices in parallel, each with citations. This is the fastest way to compare and contrast devices: training data, PCCP scope, how they handled adding new scanners, and so on.
What does the side-by-side PDF viewer mode do?
Select multiple devices, open the PDF viewer tab, and ask one question (e.g., "Describe the training data"). It queries all selected devices simultaneously with citations, so you can compare and contrast quickly.
6. Collections
With rows selected, go to the Collections tab and create a labeled collection (e.g., "Cobb Angle Project"). Reload that selection any time — before a client call, pull up the collection and ask questions across all of its devices at once.
How do you save a set of selected devices for later use?
Select the rows, go to the Collections tab, and create a labeled collection (e.g., "Cobb Angle Project"). You can reload the selection anytime and carry it into the PDF viewer and other tabs that support selections.
7. Product codes and the regulations tree
Click a product code in the results to jump to it in the regulations tree — identification text, sibling product codes, and devices you can open in a PDF viewer on the right. Click a regulation number to see its identification, special controls, and related product codes. You can also search by product code or regulation number at the top of the tree. Always read the special controls if any exist for your device — it broadens your search and sharpens pre-kickoff research.
What can you do from the regulations tree view?
Browse product codes and regulation numbers, read the identification text and special controls, browse sibling product codes, open device PDFs on the right, and search by product code or regulation number at the top of the tree.
8. Chart view
Click Show Chart and segment by regulation number (or product code) to see which regulations dominate your result set. Clicking a regulation takes you into the regulations tree. Great for spotting that most matches are, say, hardware laparoscopic devices — a cue to go back and filter.
How do you see which regulations dominate a search result set?
Click "Show Chart" and segment by Regulation Number. Clicking a regulation takes you to the regulations tree.
9. The predicate graph
Open the Predicates tab for a family-tree view of predicate relationships. Click a node to trace its parents and children; selections from search carry over pre-selected. Commonly predicated devices are worth reading — a lot of people predicated them for a reason. The visual lineage is also handy on client calls, e.g. to show how a predicate family evolved and justify why your predicate still holds.
In the predicate graph, why are commonly predicated devices worth reading?
A lot of people predicated them for a reason. Clicking a node traces parents and children, and selections from search carry over pre-selected.
10. Embeddings: the galaxy map
The Embeddings tab plots every matching document in a 2-D "galaxy map" where semantically similar devices cluster together. Hover or click clusters to explore, and let AI label the clusters for you. Embeddings beat product codes for grouping: two devices can carry different product codes (LLZ vs. QIH) yet do the same thing — the embedding captures the meaning of the intended use and device story. This is also exactly how retrieval-augmented generation (RAG) works under the hood, and it makes a great visual on client calls.
Try it yourself
Head to the search page and work through a few of these AI/ML fuzzy searches to build intuition: perivascular fat on CT · aortic valve calcification opportunistic screening on noncontrast CT · breast cancer prediction on digital pathology slides · autism detection · gestational age prediction · a hearing aid that can also detect a pulse · foundation model based analysis of ECG · large language models · penetration test. Watch how the relevance scores, intended use, and AI Performance tables tell you when results stop being meaningful.
